Saint Lukes Cancer Institute — Kansas City, Missouri

Saint Lukes Cancer Institute is a clinical research site located in Kansas City, Missouri, United States 64111.

Crixeo Health Trust Score: 46/100 (POOR). This profile has not yet been claimed by the site owner.

Saint Lukes Cancer Institute has participated in 1 clinical trials.

Therapeutic areas: Non Small-cell Lung Cancer, Locally Advanced Unresectable NSCLC, Locally Advanced Metastatic NSCLC.

Sponsors: Amgen.

Sponsor Feasibility Report

Trust Score: 46/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Saint Lukes Cancer Institute?

Saint Lukes Cancer Institute has a Crixeo Trust Score of 46/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Saint Lukes Cancer Institute conducted?

Saint Lukes Cancer Institute has 1 clinical trials on record. Their work covers Non Small-cell Lung Cancer, Locally Advanced Unresectable NSCLC, Locally Advanced Metastatic NSCLC.

Is Saint Lukes Cancer Institute accredited by Crixeo Health?

Saint Lukes Cancer Institute has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Saint Lukes Cancer Institute?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.